Investor Relations

Depomed, Inc., headquartered in Menlo Park, California, was founded in August 1995 and became a publicly traded company on the Nasdaq National Market in November 1997 under the ticker symbol, DEPO.

Depomed’s policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent, Continental Stock Transfer, directly.